Latest News and Press Releases

WIXOM, Mich., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at...

WIXOM, Mich., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI) ("Rockwell Medical" or the "Company") today announced that Stuart Paul, Chief Executive Officer, will present at...

WIXOM, Mich., May 23, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated specialty pharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney...

Conference call at 4:30 p.m. EDT today, May 10 WIXOM, Mich., May 10, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated specialty pharmaceutical company targeting...

WIXOM, Mich., May 08, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), today provided an update on its new manufacturing submission for its Calcitriol vitamin D injection, stating that...

WIXOM, Mich., May 02, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease...

Conference to be held May 5-8, in Vancouver, Canada WIXOM, Mich., May 02, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), announced today that two Triferic® abstracts have been...

  Three Poster Presentations with Data for Triferic Clinical Pharmacology and Peritoneal Dialysis Conference being held April 11-14 in Austin, TX WIXOM, Mich., April 05, 2018 (GLOBE NEWSWIRE) --...

Oral and Poster Presentations for Triferic Clinical Pharmacology and Peritoneal Dialysis Conference being held March 27-31, 2018, in Beijing China WIXOM, Mich., March 20, 2018 (GLOBE NEWSWIRE)...

Conference call at 4:30 p.m. EDT today WIXOM, Mich., March 15, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal...